Welcome to Morbus & Curis, a blog about disease and healthcare. Today’s blog post takes a look at drivers of biosimilar uptake in Europe. Biosimilars offer the potential for healthcare systems to make cost savings and improve patient access to biologic medicines. Despite this, their uptake is varied across European markets and therapeutic areas.
Activities Driving Biosimilar Uptake in Europe
Activities Driving Biosimilar Uptake in…
Activities Driving Biosimilar Uptake in Europe
Welcome to Morbus & Curis, a blog about disease and healthcare. Today’s blog post takes a look at drivers of biosimilar uptake in Europe. Biosimilars offer the potential for healthcare systems to make cost savings and improve patient access to biologic medicines. Despite this, their uptake is varied across European markets and therapeutic areas.